Canaan X L.P., Director, 10% Owner at Iterum Therapeutics plc (ITRM), bought 782,102 shares at $13.00 ($6.6M) on 2018-05-30, disclosed to the SEC on 2018-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 275,446 | $0 | 0.0% |
| 2 | $13.00 | 506,656 | $6.6M | 100.0% |
| Total | $8.42 avg | 782,102 | $6.6M | 100% |
| Filing → |
| PTGX | BUY | 2016-08-16 | $7.0M | — | Filing → |